Montreal Protocol likely in eastern Asia, with detrimental global effects on the ozone layer. A monitoring study detected fresh atmospheric releases of carbon tetrachloride from China's Shandong province, beginning sometime after 2012, and accounting for a large part of emissions exceeding global estimates under the Montreal Protocol. The year 2012 marked the 25th anniversary of the signing of the Montreal Protocol. Accordingly, the Montreal Protocol community organized a range of celebrations at the national, regional and international levels to publicize its considerable success to date and to consider the work ahead for the future. Among its accomplishments are: The Montreal Protocol was
Wiley protocol at separate times throughout the period. The protocol is promoted as differing from conventional hormone replacement therapy in several ways: The protocol also includes a follow-up program to monitor the serum of the bioidentical hormones. Wiley has stated that in her opinion, the most important aspect of the protocol is the specific schedule and levels of the hormone doses rather than their bioidentical nature. A patent was granted for the protocol in 2011 for the specific blend of hormones and dosing method. Concerns have been raised that serum levels may not be an acceptable marker for transdermally administered hormones, that